The Procurement Reflex Behind £9.9 Billion in Wasted PPE Has Not Left the NHS

For eighteen months, lorries left English warehouses carrying protective equipment that would never touch a patient. Some of it went straight to incineration, masks and gowns bought at speed and sold at a premium, unusable by the time anyone checked. The Covid inquiry's verdict on this, published this week, puts a figure on the waste: £9.9 billion of the £14.9 billion spent on PPE across the UK and devolved governments, written off entirely. Baroness Hallett's report does not accuse ministers of corruption. It does something arguably more damning. It describes a system that mistook urgency for competence, and speed for due diligence, at a scale that will take a generation to fully account for.

The temptation is to read this as history, a verdict on a government under duress in a crisis nobody had rehearsed for. That reading misses the point. The particular failure the inquiry identifies, a fast-track lane that rewarded political proximity over supplier capability, compressed vetting to a matter of hours, and left almost two-thirds of spending unrecoverable, was not a pandemic-specific aberration. It was an institutional reflex. And that reflex is visible again, in a different arena, under far less public scrutiny: the NHS's current approach to large-scale technology procurement.

The Federated Data Platform contract with Palantir is the clearest example. It was negotiated and expanded amid genuine pressure to modernise NHS data infrastructure, pressure that is real and largely justified. But the pattern of decision-making bears an uncomfortable resemblance to what the inquiry has just condemned. Limited competitive testing. A single supplier embedded early and then difficult to dislodge. Assurances about value and capability that outpaced independent verification. Where PPE procurement failed because nobody could confirm a mask would fit before the contract was signed, NHS technology procurement risks failing because nobody can confirm a platform will deliver interoperability, information governance, or genuine value for money before the dependency is locked in.

This is not an argument that Palantir, or any single vendor, is defective in the way that expired stockpiles were defective. It is an argument about process, about the conditions under which large commitments get made when institutions are under pressure to be seen acting decisively. The inquiry found that VIP lane suppliers were thirteen times more likely to win contracts than standard applicants, and disproportionately more likely to fail to deliver. NHS technology procurement has its own version of preferential access: incumbency, existing relationships with NHS England and the centre, and a political appetite for quick wins on digital transformation that discourages the kind of slow, adversarial testing a genuinely competitive process requires.

Sir Jim Mackey's centralising agenda, and the broader reduction of integrated care boards from 42 to 26, has concentrated procurement decisions in fewer hands at exactly the moment the system needs more independent scrutiny of those decisions, not less. Speed and consolidation are being sold as efficiency. The PPE inquiry's lesson is that speed without independent assurance produces liabilities that outlast the crisis that justified them. A defective mask can be incinerated. A data platform embedded across NHS trusts cannot be quietly written off if it underperforms or if information governance concerns later prove founded.

All of this does not imply that NHS executives are subject to deception on the scale that the inquiry has calculated for PPE. The comparison is structural, not moral. It is a warning about institutional muscle memory: the tendency, under pressure, to solve visible problems by loosening scrutiny rather than building the capacity to evaluate vendors properly before money and dependency are committed. The inquiry's recommendation that critical supply chains be treated as strategic national assets, built with resilience rather than convenience in mind, applies with equal force to data infrastructure as to manufacturing capacity.

Baroness Hallett has given the government eleven recommendations and a demand for fundamental change. Whether that change reaches procurement practices operating today, in far less visible corners of the NHS than emergency PPE contracts, will say more about whether the lesson has actually been learned than any ministerial statement following the report's publication.